Saudi Journal of Anaesthesia

ARTICLE
Year
: 2007  |  Volume : 1  |  Issue : 1  |  Page : 5-

Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery


Zahra M Al-Sammak1, Mohamed Falaki2, Akila A Pasha4 
1 College of Medicine and Medical Science, Arabian Gulf University and Anesthesia Department, Salmaniya Medical Complex, Bahrain
2 Faculty of Medicine, Zagazig University, Egypt and Consultant anesthetist, Anesthesia Department, Salmaniya Medical Complex, Bahrain

Correspondence Address:
Zahra M Al-Sammak
College of Medicine and Medical Science, Arabian Gulf University and Anesthesia Department, Salmaniya Medical Complex
Bahrain

Background : Perioperative blood transfusion is usually given to sickle cell disease patients to reduce or prevent perioperative morbidity. Assessment of such a practice was the subject of our study. Methods : A retrospective one year survey of sickle cell disease patients undergoing surgery at Salmaniya Medical Complex, Bahrain, was conducted. The medical records were reviewed to characterize the surgical procedure, transfusion management and perioperative complications. Results : 85 sickle cell disease patients who underwent surgery were studied. Preoperatively, 21.2% had exchange transfusion (ETX), 24.7% had simple transfusion (STX) and 54.1% had no transfusion (NTX). 14.1% of all patients had postoperative complications and 50% of those who had complications were from the laparoscopic cholecystectomy group. The incidence of sickle cell crisis postoperatively was 22.2% in ETX group, 9.5% in STX group and 4.34% in the NTX group. The incidence of acute chest syndrome postoperatively was found to be 5.55 % in the ETX group, 4.76% in the STX group and 4.34% in the NTX group. No intraoperative complications were recorded in all groups. All patients who had postoperative complications had a preoperative HBSS > 40%. Conclusion : Exchange transfusion doesn«SQ»t prevent perioperative complications of sickle cell disease. HBSS > 40% carries a higher risk of postoperative complications.


How to cite this article:
Al-Sammak ZM, Falaki M, Pasha AA. Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery.Saudi J Anaesth 2007;1:5-5


How to cite this URL:
Al-Sammak ZM, Falaki M, Pasha AA. Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery. Saudi J Anaesth [serial online] 2007 [cited 2022 Aug 15 ];1:5-5
Available from: https://www.saudija.org/article.asp?issn=1658-354X;year=2007;volume=1;issue=1;spage=5;epage=5;aulast=Al-Sammak;type=0